imatinib mesylate has been researched along with Hepatitis, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enrich, B; Gastl, G; Ludwiczek, S; Rumpold, H; Tilg, H; Weiss, G; Wolf, AM; Wolf, D | 1 |
1 other study(ies) available for imatinib mesylate and Hepatitis, Animal
Article | Year |
---|---|
The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation.
Topics: Animals; Benzamides; Cell Death; Cells, Cultured; Chemical and Drug Induced Liver Injury; Concanavalin A; Female; Hepatitis, Animal; Humans; I-kappa B Proteins; Imatinib Mesylate; Inflammation; Interleukin-10; Lipopolysaccharides; Macrophages; NF-kappa B; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Necrosis Factor-alpha | 2005 |